RxDoctor Payments Data

Brandon Jonard, MD

Orthopaedic Surgery · Cleveland, OHNPI 1336567742

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Stryker at 53.4% of the total. 2025 is the largest year on record at $6,645, more than ten times the $52 reported in 2021.

$11,436in general payments, 2019–2025

Across 71 payments — averaging $161.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Bone Support Inc.$3K
  • Deciphera Pharmaceuticals Inc.$1K
  • Onkos Surgical, Inc.$268
  • Johnson & Johnson$184
  • Icotec Medical Inc.$137
  • plus $208 from 7 others
$20,730in research payments, 2019–2025

Across 3 payments — averaging $6910.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$21K

What the payments were for

  • Speaking & faculty fees$1,20010%
  • Travel & lodging$6,37356%
  • Food & beverage$3,86334%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,436 in reported general payments places this provider in the 70th percentile of 794 orthopaedic surgery providers in Ohio.

See all orthopaedic surgery providers in Ohio →

Medicare billing

Part B allowed, 2024
$91,523
Medicare patients
193
Services billed
453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin11$125
Oxycodone Hcl21$82
Meloxicam16$71
Alprazolam13$7

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Cleveland

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →